Relitren - E 200 mg Injection
Relitren - E 200 mg Injection is an injectable pharmaceutical formulation. Its exact active ingredient, concentration and composition should be verified from the manufacturer's packaging before providing product-specific therapeutic information. The product's intended application and regulatory status should be confirmed with the manufacturer and relevant authorities. Proper storage, handling and product-quality precautions should be followed according to the official product documentation. It should not be used for human self-administration or non-medical performance enhancement. Any use must comply with applicable medical and regulatory requirements.
Contact Details – Phoenix Exim
Contact No. / WhatsApp:
+91-9307610860
+91-9860818372
Email: phoenixexim0@gmail.com
